State of Tennessee, Department of Treasury
DAWN

State of Tennessee, Department of Treasury’s Day One Biopharmaceuticals DAWN Stock Holding History

State of Tennessee, Department of Treasury’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-25,460
Closed -$253K – 1654
2022
Q1 		$253K Hold
25,460
– – ﹤0.01% 1560
2021
Q4 		$429K Buy
+25,460
New +$523K ﹤0.01% 1402

Other funds holding DAWN

CPX
Canaan Partners XI Menlo Park, California $127M AUM 217.49% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State of Tennessee, Department of Treasury's DAWN Position: Q2 2022 in Review

State of Tennessee, Department of Treasury sold out of Day One Biopharmaceuticals (DAWN) in Q2 2022, closing a stake of 25,460 shares — an estimated $253K sold.

State of Tennessee, Department of Treasury first reported a position in DAWN in Q4 2021 and held it in 2 quarters. The position peaked at $429K in Q4 2021. 87 funds tracked by Wall St. Rank hold DAWN as of Q2 2022.

  • State of Tennessee, Department of Treasury reported no remaining Day One Biopharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • State of Tennessee, Department of Treasury sold 25,460 Day One Biopharmaceuticals shares in Q2 2022, an estimated $253K.
  • State of Tennessee, Department of Treasury first reported a position in Day One Biopharmaceuticals in Q4 2021 and held it in 2 quarters.
  • State of Tennessee, Department of Treasury's Day One Biopharmaceuticals position peaked at $429K in Q4 2021.
  • 87 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2022.

Based on State of Tennessee, Department of Treasury's 13F filing for Q2 2022, filed 15 Aug 2022.